Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 20;7(6):ofaa178.
doi: 10.1093/ofid/ofaa178. eCollection 2020 Jun.

Which Patients Discharged to Home-Based Outpatient Parenteral Antimicrobial Therapy Are at High Risk of Adverse Outcomes?

Sara C Keller  1 , Nae-Yuh Wang  2 , Alejandra Salinas  3 , Deborah Williams  4 , Jennifer Townsend  3 , Sara E Cosgrove  5
Affiliations

Which Patients Discharged to Home-Based Outpatient Parenteral Antimicrobial Therapy Are at High Risk of Adverse Outcomes?

Sara C Keller et al. Open Forum Infect Dis. .

Abstract

Background: Patients increasingly receive home-based outpatient parenteral antimicrobial therapy (OPAT). Understanding which patients might be at higher risk of complications is critical in effectively triaging resources upon and after hospital discharge.

Methods: A prospective cohort of patients discharged from 1 of 2 academic medical centers in Baltimore, Maryland, between March 2015 and December 2018 were consented and randomly divided into derivation and validation cohorts for development of a risk score for adverse OPAT outcomes. Data from the derivation cohort with the primary outcome of a serious adverse outcome (infection relapse, serious adverse drug event, serious catheter complication, readmission, or death) were analyzed to derive the risk score equation using logistic regression, which was then validated in the validation cohort for performance of predicting a serious adverse outcome.

Results: Of 664 patients in the total cohort, half (332) experienced a serious adverse outcome. The model predicting having a serious adverse outcome included type of catheter, time on OPAT, using a catheter for chemotherapy, using a catheter for home parenteral nutrition, being treated for septic arthritis, being on vancomycin, being treated for Enterococcus, being treated for a fungal infection, and being treated empirically. A score ≥2 on the serious adverse outcome score had a 94.0% and 90.9% sensitivity for having a serious adverse outcome in the derivation and validation cohorts, respectively.

Conclusions: A risk score can be implemented to detect who may be at high risk of serious adverse outcomes, but all patients on OPAT may require monitoring to prevent or detect adverse events.

Keywords: OPAT; antibiotic complication; catheter complications; home infusion.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Risk score equations for an outpatient parenteral antimicrobial therapy (OPAT)–related serious adverse outcome and any OPAT-related adverse outcome, respectively.
See this image and copyright information in PMC

References

    1. Norris AH, Shrestha NK, Allison GM, et al. . 2018 Infectious Diseases Society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy. Clin Infect Dis 2019; 68:e1–e35. - PubMed
    1. Berrevoets MAH, Oerlemans AJM, Tromp M, et al. . Quality of outpatient parenteral antimicrobial therapy (OPAT) care from the patient’s perspective: a qualitative study. BMJ Open 2018; 8:e024564. - PMC - PubMed
    1. Keller SC, Williams D, Gavgani M, et al. . Rates of and risk factors for adverse drug events in outpatient parenteral antimicrobial therapy. Clinical Infect Dis 2018; 66:11–9. - PMC - PubMed
    1. Saini E, Ali M, Du P, et al. . Early infectious disease outpatient follow-up of outpatient parenteral antimicrobial therapy patients reduces 30-day readmission. Clin Infect Dis 2019; 69:865–8. - PubMed
    1. Hamad Y, Lane MA, Beekmann SE, Polgreen PM, Keller SC. Perspectives of United States-based infectious diseases physicians on outpatient parenteral antimicrobial therapy practice. Open Forum Infect Dis 2019; 6:XXX–XX. - PMC - PubMed